AAAAAA

   
Results: 1-12 |
Results: 12

Authors: FIBBI G PUCCI M SERNI U CERINIC MM DELROSSO M
Citation: G. Fibbi et al., ANTISENSE TARGETING OF THE UROKINASE RECEPTOR BLOCKS UROKINASE-DEPENDENT PROLIFERATION, CHEMOINVASION, AND CHEMOTAXIS OF HUMAN SYNOVIAL-CELLS AND CHONDROCYTES IN-VITRO, Proceedings of the Association of American Physicians, 110(4), 1998, pp. 340-350

Authors: LEMMEL EM REID DM NUKI G AVOUAC B BARDIN T BOUVENOT G CAUWENBERGE H CLUZEL M DEVOLGELAER JP DUFF GW EMERY P ETHGEN D KREUTZ G MENKES CJ REIDEL H SERNI U VANDERAUWERA P VEYS E WHITEGUAY B REGINSTER JY
Citation: Em. Lemmel et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, British journal of rheumatology, 37(2), 1998, pp. 211-215

Authors: BARTOLONI A STROHMEYER M SABATINELLI G BENUCCI M SERNI U PARADISI F
Citation: A. Bartoloni et al., FALSE-POSITIVE PARASIGHT(TM)-F TEST FOR MALARIA IN PATIENTS WITH RHEUMATOID-FACTOR, Transactions of the Royal Society of Tropical Medicine and Hygiene, 92(1), 1998, pp. 33-34

Authors: ADAMI S BUFALINO L CERVETTI R DIMARCO C DIMUNNO O FANTASIA L ISAIA GC SERNI U VECCHIET L PASSERI M CASTIGLIONE GN GARDINI F LETIZIA G OCCHIPINTI L PARDINI N AGAMENNONE M SCIOLLA A MATUCCI A RIBOLDI R COSTI D DALLAGLIO E PEDRAZZONI M
Citation: S. Adami et al., IPRIFLAVONE PREVENTS RADIAL BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS OVER 2 YEARS, Osteoporosis international, 7(2), 1997, pp. 119-125

Authors: BARDAZZI G MANNONI A DALBASIO G BONANOMI AG TRALLORI G BENUCCI M SERNI U PACINI F
Citation: G. Bardazzi et al., SPONDYLOARTHRITIS IN PATIENTS WITH ULCERATIVE-COLITIS, The Italian Journal of Gastroenterology, 29(6), 1997, pp. 520-524

Authors: GENNARI C ADAMI S AGNUSDEI D BUFALINO L CERVETTI R CREPALDI G DIMARCO C DIMUNNO O FANTASIA L ISAIA GC MAZZUOLI GF ORTOLANI S PASSERI M SERNI U VECCHIET L
Citation: C. Gennari et al., EFFECT OF CHRONIC TREATMENT WITH IPRIFLAVONE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS, Calcified tissue international, 61, 1997, pp. 19-22

Authors: DOUGADOS M DEVOGELAER JP ANNEFELDT M AVOUAC B BOUVENOT G COOPER C DIEPPE P ETHGEN D GARATTINI S JONES EA KAUFMAN JM LEEMING M LEMMEL EM LOHMANDER S MENKES CJ NUKI G PAOLOZZI L PUJOL JP ROVATI L SERNI U SPECTOR T TSOUDEROS Y VEYS EM WESELOH G REGINSTER JY
Citation: M. Dougados et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS, Annals of the Rheumatic Diseases, 55(8), 1996, pp. 552-557

Authors: SERNI U FIBBI G ANICHINI E ZAMPERINI A PUCCI M MANNONI A MATUCCI A BENUCCI M DELROSSO A DELROSSO M
Citation: U. Serni et al., PLASMINOGEN-ACTIVATOR AND RECEPTOR IN OSTEOARTHRITIS, Journal of rheumatology, 22, 1995, pp. 120-122

Authors: PASERO G MARCOLONGO R SERNI U PARNHAM MJ FERRER F
Citation: G. Pasero et al., A MULTICENTER, DOUBLE-BLIND COMPARATIVE-STUDY OF THE EFFICACY AND SAFETY OF ACECLOFENAC AND DICLOFENAC IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Current medical research and opinion, 13(6), 1995, pp. 305-315

Authors: FIBBI G SERNI U MATUCCI A MANNONI A PUCCI M ANICHINI E DELROSSO M
Citation: G. Fibbi et al., CONTROL OF THE CHONDROCYTE FIBRINOLYTIC BALANCE BY THE DRUG PIROXICAM- RELEVANCE TO THE OSTEOARTHRITIC PROCESS, Journal of rheumatology, 21(12), 1994, pp. 2322-2328

Authors: PASERO G RUJU G MARCOLONGO R SENESI M SERNI U MANNONI A ACCARDO S SERIOLO B COLOMBO B LIGNIERE GC CONSOLI G DESANTIS D FERRI S AMORESANO C FRIZZIERO L RETA M GIORGIANNI G MARTORANA U TERMINE S MATTARA L FRANCESCHINI M ORIENTE P SCARPA R PERPIGNANO G BOGLIOLO A TORRI G TROTTA F GOVONI F
Citation: G. Pasero et al., ACECLOFENAC VERSUS NAPROXEN IN THE TREATMENT OF ANKYLOSING-SPONDYLITIS - A DOUBLE-BLIND, CONTROLLED-STUDY, Current therapeutic research, 55(7), 1994, pp. 833-842

Authors: MANNONI A ALTMAN RD MUNIZ OE SERNI U DEAN DD
Citation: A. Mannoni et al., THE EFFECTS OF METHOTREXATE ON NORMAL AND OSTEOARTHRITIC LAPINE ARTICULAR-CARTILAGE, Journal of rheumatology, 20(5), 1993, pp. 849-855
Risultati: 1-12 |